Clinical Trials Browser

Phase 1 × Terminated × PM 01183 × Clear all

NCT04610658 2024-04-02

Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC

Phase 1 Terminated

Small Cell Lung Carcinoma